Predictive diagnosis by molecular methods will change the scientific basis of prognostics. At the same time, it will change the ethical dimensions of the relation among patients, their doctors and other providers of care.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Personal genome testing: Test characteristics to clarify the discourse on ethical, legal and societal issues
BMC Medical Ethics Open Access 14 June 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kevles, D.J. In the Name of Eugenics: Genetics and the Uses of Human Heredity (University of California Press, Berkeley and Los Angeles, California, 1985).
Proctor, R.N. Racial Hygiene: Medicine Under the Nazis (Harvard University Press, Cambridge, Massachusetts, and London, England, 1988).
Cook-Deagan, R.M. The genesis of the Human Genome Project. Mol. Genet. Med. 1, 1–75 (1991).
Myers, M.F., Bernhardt, B.A., Tambor, E.S. & Holtzman, N.A. Involving consumers in the development of an educational program for cystic fibrosis carrier screening. Am. J. Hum. Genet. 54, 719–726 (1994).
Tambor, E.S. et al. Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization. Am. J. Hum. Genet. 55, 626–637 (1994).
Fanos, J.H. & Johnson, J.P. Perception of carrier status by cystic fibrosis siblings. Am. J. Hum. Genet. 57, 431–438 (1995).
Moseley, R., McCrary, S.V. & Allen, W.L. The Ethical, Legal and Social Implications of Predictive Genetic Testing for Health Insurance: Policy Analysis and Recommendations. A Preliminary Report of the Human Genome Insurance Project (Medical Humanities Program, University of Florida College of Medicine, 1993).
Task Force on Genetic Information and Insurance, NIH-DOE Working Group on Ethical, Legal and Social Implications of Human Genome Research. Genetic Information and Health Insurance. Report of the Task Force on Genetic Information and Insurance (National Center for Human Genome Research, National Institutes of Health, Bethesda, Maryland, 1993).
Mehlman, M.J. et al. Coverage of genetic technologies under national health reform. Am. J. Hum. Genet. 55, 1054–1060 (1994).
Marshall, E. NIH told to reconsider crime meeting. Science 262, 23–24 (1993).
Hippocrates. The Art viii; Decorum, xvi (trans. Jones, W.H.S.) 204, 299 (Cambridge, Massachusetts, Harvard Univ. Press, 1923).
Dunlop, M.G. Colorectal cancer genetics. Cancer Biol. 3, 131–140 (1992).
Motulsky, A.G. & Brunzell, J.D. The genetics of coronary atherosclerosis. in The Genetic Basis of Common Diseases (eds. King, R.A., Rotter, J.I. & Motulsky, A.G.) 150–169 (Oxford Univ. Press, New York, New York, and Oxford, UK, 1992).
Rotter, J.I., Vadheim, C.M. & Rimoin, D.L. Diabetes mellitus. in The Genetic Basis of Common Diseases (eds. King, R.A., Rotter, J.I. & Motulsky, A.G.) 413–481 (Oxford Univ. Press, New York, New York, and Oxford, UK, 1992).
Groop, L.C. et al. Association between polymorphism of the glycogen synthetase gene and non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 328, 10–14 (1993).
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088–2090 (1994).
Hippocrates. Epidemics I, xi. (trans. Jones, W.H.S.) 165 (Harvard Univ. Press, Cambridge, Massachusetts, 1923).
Bloch, M. et al. Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk. Am. J. Med. Genet. 42, 499–507 (1992).
Huggins, M. et al. Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am. J. Med. Genet. 42, 508–515 (1992).
Wiggins, S. et al. The psychological consequences of predictive testing for Huntington's disease. N. Engl. J. Med. 327, 1401–1405 (1992).
Yesley, M.S. & Roth, M.J.R. ELSI Bibliography: Ethical, Legal and Social Implications of the Human Genome Project (National Technical Information Service, Springfield, Virginia, 1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jonsen, A., Durfy, S., Burke, W. et al. The advent of the ‘unpatients’. Nat Med 2, 622–624 (1996). https://doi.org/10.1038/nm0696-622
Issue Date:
DOI: https://doi.org/10.1038/nm0696-622
This article is cited by
-
Personal genome testing: Test characteristics to clarify the discourse on ethical, legal and societal issues
BMC Medical Ethics (2011)
-
The Ethical Challenges of Direct-to-Consumer Genetic Testing
Journal of Business Ethics (2007)
-
Private and Public Eugenics: Genetic Testing and Screening in India
Journal of Bioethical Inquiry (2007)
-
Vaccines for tumour prevention
Nature Reviews Cancer (2006)
-
Genetic Risk, Medical Education, Public Understanding of Genetics, and Evolutionary Medicine: The Challenges of Genetic Counselling for Complex Disorders
Topoi (2004)